Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-06-24

Clinical Trial Update: A Study Based on Medical Records in Spain That Looks at Diarrhoea Control in People With Pulmonary Fibrosis Who Are Taking Nintedanib

View source ↗

Summary

A completed medical-records study in Spain assessed diarrhea management in patients with idiopathic pulmonary fibrosis treated with nintedanib.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Nintedanib (nintedanib)

Snippet

Sponsor: Boehringer Ingelheim | Conditions: Idiopathic Pulmonary Fibrosis, Diarrhoea | Status: COMPLETED